The paraoxonase Leu–Met54 and Gln–Arg191 gene polymorphisms are not associated with the risk of coronary heart disease
- 1 October 2000
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 152 (2), 421-431
- https://doi.org/10.1016/s0021-9150(99)00489-x
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Does paraoxonase play a role in susceptibility to cardiovascular disease?Molecular Medicine Today, 1999
- Paraoxonase and coronary heart diseaseCurrent Opinion in Lipidology, 1998
- Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosisNature, 1998
- Oxidized Lipids in Atherogenesis: Formation, Destruction and ActionThrombosis and Haemostasis, 1997
- Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.Journal of Clinical Investigation, 1995
- HDL, its enzymes and its potential to influence lipid peroxidationAtherosclerosis, 1995
- Atherosclerosis: Basic MechanismsCirculation, 1995
- Antioxidative activity of high density lipoproteins in vivoAtherosclerosis, 1993
- Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitusAtherosclerosis, 1991
- High-density lipoprotein inhibits the oxidative modification of low-density lipoproteinBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990